Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Surgery|October 18, 2011
High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenomaTakanobu Utsumi, Koji Kawamura, Takashi Imamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 25, 2025
Clinical Predictors of Fluoroquinolone-Resistant Escherichia coli in Transrectal Ultrasound-Guided Prostate Biopsy: Insights for Tailored ProphylaxisTakatoshi Somoto, Takanobu Utsumi, Naoki Ishitsuka, et al.
Cancers|February 13, 2026
High Oncological Efficacy of BCG Maintenance Therapy for Primary High-Grade T1 Urothelial Carcinoma of the BladderTakahide Noro, Naoto Kamiya, Naoki Ishitsuka, et al.
International Journal of Clinical Oncology|May 28, 2018
Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumorKen Wakai, Takanobu Utsumi, Kei Yoneda, et al.
Japanese Journal of Clinical Oncology|February 12, 2014
Development of nomogram to non-steroidal antiandrogen sequential alternation in prostate cancer for predictive modelNaoto Kamiya, Hiroyoshi Suzuki, Kensaku Nishimura, et al.
Microcirculation (New York, N.Y. : 1994)|December 30, 2025
Impact of Androgen Deprivation Therapy on Choroidal Microcirculation Assessed Using Laser Speckle FlowgraphyRyuya Hashimoto, Ryo Oka, Naoki Fujioka, et al.
Cancers|February 26, 2025
Multidisciplinary Treatment for Lymphorrhea and Chylorrhea Following Lymph Node Dissection for Genitourinary CancerNaoto Kamiya, Takahide Noro, Taro Okazaki, et al.
International Journal of Cancer|July 8, 2003
Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasionNaoto Kamiya, Takashi Kishimoto, Hiroyoshi Suzuki, et al.
Cancers|June 26, 2026
Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI-PARP-Radioligand EraTakatoshi Somoto, Takanobu Utsumi, Rino Ikeda, et al.
Cancers|June 26, 2026
Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic MonitoringTakahide Noro, Takanobu Utsumi, Rino Ikeda, et al.
Pageof 9